Source: AllCare Physio/ Facebook
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Healthia (HLA) purchases two AllCare Physiotherapy stores and a John Holme Optometrist for $2.46 million
  • The company has also entered into an agreement to purchase Anytime Physio in Newstead, Queensland
  • The newly purchased business are expected to contribute a revenue of $3.95 million and EBITDA of $640,000
  • Managing Director, Wesley Coote, says the company’s vision is to build the leading allied health care business in the Australian market
  • On market close, Healthia was down 6.25 per cent, trading at $1.80 per share

Healthia (HLA) has agreed to purchase two AllCare Physiotherapy stores and a John Holme Optometrist for $2.46 million.

The physiotherapy clinics are located in Hobart, Tasmania, while the optometrist includes two stores in Northern Queensland.

The company has also entered into an agreement to purchase Anytime Physio in Newstead, Queensland.

The newly purchased businesses are expected to contribute a revenue of $3.95 million and earnings before interest, tax, depreciation and amortisation (EBITDA) of $640,000.

Managing Director, Wesley Coote, said the company’s vision is to build the leading allied health care business in the Australian market.

“Our key target sectors of Bodies and Minds, Feet and Ankles, and Eyes and Ears have a collective addressable market of $9.8 billion,” Mr Coote said.

“We have a proven management team and a clinician and patient first culture and are excited to have these businesses joining our growing allied health network.”

Since listing on the ASX in September 2018, Healthia has grown its portfolio of allied health businesses from 104 to 217. This marks a 109 per cent growth and the company will continue adding value to its portfolio of assets.

On market close, Healthia was down 6.25 per cent, trading at $1.80 per share.

HLA by the numbers
More From The Market Online

BlinkLab partnership with US smart-tech Turning Pointe raises hopes for autism kids

BlinkLab partners with US-based Turning Pointe Autism Foundation for clinical study ahead of its FDA registration…

Little Green Pharma closely eyeing USA’s legal downgrade of Cannabis danger

Overnight, the Biden government did something sure to give their counterparts a stir – the USA…

OncoSil’s cancer device shows shrink in pancreatic tumours

OncoSil's cancer device shows shrink in pancreatic tumours at a study conducted at the Royal Adelaide…
The Market Online Video

Why Princeton Professor rates BlinkLab’s autism & ADHD screening app

In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and…